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amino acid possessing similar structure to leucine but shorter side-
chain. The mutation from leucine to valine is pathogenic despite
the fact that it is a substitution to a similar amino acid attesting the
conservation and functional importance of this protein motif. In
K14, a type 1 keratin expressed in the basal keratinocytes, there was
one report with a mutation at residue 7 of HIM (L122F), resulting
in a milder disease phenotype of epidermolysis bullosa simplex
(Yamanishi et al, 1994). Phenylalanine is a hydrophobic amino acid
similar to leucine but having a larger side chain. This case further
supports the idea that the mutation at HIM residue 7 of type I
keratin is pathogenic, even if the mutation is a substitution to a
similar, hydrophobic residue. More cases should be accumulated to
clarify the genotype-phenotype relationship of the mutation at this
residue.
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Compound Heterozygous TGM1 Mutations Including a Novel
Missense Mutation L204Q in a Mild Form of Lamellar
Ichthyosis
To the Editor:
Since the identi®cation of TGase 1 gene (TGM1) mutations in a
number of families with lamellar ichthyosis (LI) in 1995 (Huber et
al, 1995; Russell et al, 1995), additional TGM1 mutations have
been reported in LI families, despite the fact that LI may be
genetically heterogeneous (Parmentier et al, 1996; Fischer et al,
2000; Virolainen et al, 2000). Whereas genotype/phenotype
correlations in LI have been studied for several years, the exact
nature of the relationship has yet to be fully elucidated (Hennies et
al, 1998; Laiho et al, 1997, 1999; Shevchenko et al, 2000).
In this study, we have identi®ed the heterozygous TGM1
mutations, L204Q and R306W, in a patient with mild lamellar
ichthyosis who showed a unique but restricted distribution of
lamellar scales.
The patient, a Japanese female and the third child of
nonconsanguineous parents, was born by normal vaginal delivery
and was not a collodion baby. During the perinatal period, she was
generally healthy and the skin covering her entire body appeared
normal without ectropion or eclabium (Fig 1a). She had no other
congenital anomalies. During infancy, thick scales appeared, mainly
on the trunk, and the severity of the scaling was stable throughout
her life without use of systemic retinoids or topical steroid
treatment, although the scaling worsened and affected areas
enlarged in the summer.
The patient's elder sister died when she was 1 wk old. The cause
of the sister's death was not known in detail except that she suffered
from ichthyosis. There was no other family history of congenital
ichthyosis and the patient's three remaining children displayed no
symptoms related to ichthyosis.
Physical examination of the patient at 56 years of age revealed
dark gray, thick, lamellar scales covering the neck, abdomen, center
of the back, and bilateral axillae (Fig 1b±d). The skin on her face
and extremities appeared normal and hyperkeratosis was not seen
on either her palms or her soles. Her hair, teeth, and nails also
appeared normal. Extracutaneous symptoms were not found.
Steroid sulfatase activity in the peripheral blood sample was normal.
Light microscopy of the lesional skin sample from the patient
showed marked hyperkeratosis with only a small number of
parakeratotic cells. Electron microscopic examination revealed the
disturbance of thickening of the corni®ed cell envelope during the
keratinization of the patient's epidermis.
Immuno¯uorescent labeling was performed using goat poly-
clonal anti-TGase 1 antibody (Kim et al, 1992, 1995) and rabbit
polyclonal anti-TGase 3 antibody (Tarcsa et al, 1997) (generous
gifts from Dr. Soo-Youl Kim) as described previously (Akiyama et al,
1999). Immuno¯uorescence demonstrated a reduced expression of
the TGase 1 molecule in the granular layer of patient's epidermis
(Fig 2a), although TGase 3 expression was normal (Fig 2b).
In situ TGase activity assay was performed using monodansylca-
daverine as a substrate in the patient's skin as described previously
(Aeschlimann et al, 1993; Hohl et al, 1998; Akiyama et al, 2000). At
pH 8.4 buffer conditions for the detection of both TGases 1 and 3
activity, cytoplasmic and weak membranous labeling was observed
in the granular layer cells both within the patient's epidermis and in
the control normal human epidermis (Fig 2c, d). At pH 7.4 buffer
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conditions for the detection of TGase 1 activity only (Raghunath et
al, 1998), membranous labeling was seen in the patient's epidermis,
although this was weaker than that in control epidermis (Fig 2e, f).
TGases 1 and 3 undergo proteolytic activation by the cysteine
protease calpains; however, calpains are also known to inactivate
TGase 2 (Kim and Bae, 1998; Zhang et al, 1998). Thus, for the
precise evaluation of the TGase 1 activity in the patient's epidermis,
several cryostat sections were preincubated in m-calpain (calpain I)
(Sigma, St. Louis, MO) solution before the in situ TGase reaction at
pH 7.4 buffer condition. After calpain digestion, TGase 2 activity
mainly in the basal layer was diminished and membranous TGase 1
activity was clearly detected, although membranous TGase 1
activity in the granular layer of the patient's epidermis (Fig 2g) was
still weaker than that of control normal skin (Fig 2h).
The strategy for the mutation search was performed as previously
reported (Akiyama et al, 2001). Brie¯y, genomic DNA isolated
from peripheral blood was subjected to polymerase chain reaction
(PCR) ampli®cation, followed by direct automated sequencing,
and veri®cation of the mutation by restriction enzyme digestions.
Most oligonucleotide primers used for ampli®cation of all 15 exons
of TGM1 have been reported elsewhere (Laiho et al, 1997). For
ampli®cation of exon 4, the following primers were used: sense
primer 5¢-GTCCCAGGCTCCATCCCCTCTCCT-3¢ and anti-
sense primer 5¢-TCCCTGTCTTTCCCTCCCATCTAC-3¢. For
ampli®cation of exons 5 and 6, the following primers were used:
sense primer 5¢-AACTGGCCAGAAGTAGGTGAG-3¢ and anti-
sense primer 5¢-AGTATCCTTTACAGGGCAGGG-3¢ (Laiho et
al, 1997).
Direct sequencing of the proband's PCR product showed a T-
to-A transition at position 2582 in exon 4 of TGM1, resulting in
the change of a codon for leucine (CTG) to glutamine (CAG) at
codon 204 (L204Q) [sequence and codon numbering according to
Kim et al (1992)] (Fig 1f). In addition, sequence analysis of the
proband's PCR product showed a C-to-T transition at position
3404 in exon 6, resulting in the change of a codon for arginine
(CGG) to tryptophan (TGG) at codon 306 (R306W) (Fig 1g).
The patient's mother was also found to be heterozygous for
mutation R306W with sequencing (data not shown). The father's
DNA was not available because he had previously died. These
mutations were not found in 50 normal unrelated Japanese
alleles (25 normal unrelated Japanese individuals) by sequencing
analysis, and were not likely to be a polymorphism (data not
shown). Direct sequencing of all 15 exons and exon-intron borders
of TGM1 failed to detect any other pathogenic mutation in the
proband's DNA.
Based on the data from clinical, ultrastructural, and immunohis-
tologic studies, together with the mutation data, this patient should
be diagnosed as a mild form of LI who is compound heterozygous
for two TGM1 missense mutations. One of them, R306W, has
been reported previously in a LI patient1 and the other, L204Q, is a
novel mutation.
According to the protein modeling of TGase 1 based on the
structure of the human factor XIIIa subunit (Yee et al, 1994), the
novel mutation L204Q in the b-sandwich domain of this case was
suggested to alter protein folding, which can in turn affect the
protein stability of TGase 1, as suggested in other missense
1Park K-B, Yang J-M, Nam K, Cho M-O, Yoneda K, Lee E-S: Novel
mutations in transglutaminase 1 gene in lamellar ichthyosis. J Invest Dermatol
114:826, 2000 (abstr.)
Figure 1. Clinical features of a mild form of lamellar ichthyosis and missense mutations L204Q and R306W in TGM1 in the family.
During the perinatal period, the facial skin appeared to be normal without ectropion and eclabium (a). At 56 y of age, thick, gray scales are seen only
in the abdomen (b), the center of the back (c), and the axillae (d). (e) Pedigree of the family. The proband is indicated with an arrow (3). Genomic
DNA samples were studied from the proband (3) and her mother (2). (f) Direct sequence analysis of exon 4 of the proband's DNA reveals a T-to-A
transition at codon 204 (L204Q). (g) Direct sequence analysis of exon 6 of the proband's DNA reveals a C-to-T transition at codon 306 (R306W).
The mother also has the R306W mutation (data not shown).
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mutations in the b-sandwich domain (Laiho et al, 1997). This
instability may result in rapid degradation of the TGase 1
polypeptide and reduced TGase 1 activity in the patient's
epidermis.
Among the LI cases in which causative TGM1 mutations are
known, the mild phenotype of this case has not previously been
described in the literature. A case of LI carrying a missense
mutation R142C in the b-sandwich domain and a mutation in the
splice acceptor site of intron 5 resulting in a frame shift and
premature termination at codon 293 reportedly showed localized
patchy ichthyotic lesions only in the temporal region and on the
right side of the trunk (Laiho et al, 1999), although the phenotype
was quite different from that of this case.
The precise mechanism of localized distribution of the lamellar
scaling in our patient is still unknown; however, one explanation
may be that the defect in TGase 1 activity was somewhat mild in
the patient's epidermis and additional accelerating local skin
conditions may be necessary for the formation of fully developed
lamellar scaling. Considering the distribution pattern of the skin
lesion and the clinical history that the affected areas enlarged in the
summer and became smaller in the winter, increased water content
and raised pH in the stratum corneum might play an important role
in formation of lamellar scales in this patient.
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